total cases of pmws and pcv2- associated disease at isu-vdl 1993 1994 1995 1996 1997 1998 1999 14 15...

23
Total Cases of PMWS and Total Cases of PMWS and PCV2-Associated Disease PCV2-Associated Disease at ISU-VDL at ISU-VDL 1993 1994 1995 1996 1997 1998 1999 14 15 18 37 130 449* full year using PCV IHC as routine diagnost 11

Upload: reynold-hutchinson

Post on 29-Dec-2015

213 views

Category:

Documents


0 download

TRANSCRIPT

Total Cases of PMWS and PCV2-Total Cases of PMWS and PCV2-Associated Disease at ISU-VDLAssociated Disease at ISU-VDL

Total Cases of PMWS and PCV2-Total Cases of PMWS and PCV2-Associated Disease at ISU-VDLAssociated Disease at ISU-VDL

19931993 19941994 19951995 19961996 19971997 19981998 19991999

1414 1515 1818 3737 130130 449*449*

* First full year using PCV IHC as routine diagnostic tool.* First full year using PCV IHC as routine diagnostic tool.

1111

Cases of Cases of pneumoniapneumonia submitted to submitted to the ISU-VDL from 1993-1999the ISU-VDL from 1993-1999

PRRSPRRS

MhyoMhyo

PmultPmult

SIVSIV

APPAPP

PCV2PCV2

Dz.Dz.

120120

218218

360360

117117

262262

——

19931993

367367

357357

376376

175175

235235

——

19941994

708708

417417

563563

291291

220220

00

19951995

714714

624624

638638

384384

298298

11

19961996

869869

731731

653653

447447

271271

2020

19971997

10X10X

4X4X

2X2X

6X6X

FlatFlat

290X290X

TrendTrend

859859

894894

715715

350350

230230

111111

19981998

11681168

867867

815815

694694

178178

290290

19991999

PPostweaning ostweaning MMultisystemic ultisystemic WWasting asting SSyndrome (PMWS)yndrome (PMWS)

primarily in 10-20 week old pigs in the primarily in 10-20 week old pigs in the U.S.U.S.

pneumoniapneumonia wastingwasting anemia, paleness, +/- ictericanemia, paleness, +/- icteric +/- diarrhea+/- diarrhea 2-50% morbidity (usually < 10%)2-50% morbidity (usually < 10%) mortality of affected pigs may approach mortality of affected pigs may approach

100%100%

0%10%20%30%40%50%60%70%80%

Clinical Signs of PMWS

Age of Onset of PMWSAge of Onset of PMWS

-5-5

00

55

1010

1515

2020

2525

3030

3535

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20

Age in WeeksAge in Weeks

Cas

esC

ases

Gross Lesions of PMWSGross Lesions of PMWSGross Lesions of PMWSGross Lesions of PMWS

LungsLungs• diffusely red-tan, noncollapsed, rubbery, with diffusely red-tan, noncollapsed, rubbery, with

variable amounts of cranioventral consolidationvariable amounts of cranioventral consolidation

Lymph nodesLymph nodes• diffusely enlarged and tandiffusely enlarged and tan

Other less common lesionsOther less common lesions• Icterus, gastric ulcers, skin lesions (PDNS), Icterus, gastric ulcers, skin lesions (PDNS),

enlarged kidneys, swollen or atrophied liverenlarged kidneys, swollen or atrophied liver

Gross lesions are rarely diagnostic - very Gross lesions are rarely diagnostic - very similar to PRRSsimilar to PRRS

LungsLungs• diffusely red-tan, noncollapsed, rubbery, with diffusely red-tan, noncollapsed, rubbery, with

variable amounts of cranioventral consolidationvariable amounts of cranioventral consolidation

Lymph nodesLymph nodes• diffusely enlarged and tandiffusely enlarged and tan

Other less common lesionsOther less common lesions• Icterus, gastric ulcers, skin lesions (PDNS), Icterus, gastric ulcers, skin lesions (PDNS),

enlarged kidneys, swollen or atrophied liverenlarged kidneys, swollen or atrophied liver

Gross lesions are rarely diagnostic - very Gross lesions are rarely diagnostic - very similar to PRRSsimilar to PRRS

Microscopic Lesions of PMWSMicroscopic Lesions of PMWSMicroscopic Lesions of PMWSMicroscopic Lesions of PMWS Lung LesionsLung Lesions

• Bronchial and bronchiolar epithelial attenuation, Bronchial and bronchiolar epithelial attenuation, hyperplasia, erosion, luminal obliteration & epithelial hyperplasia, erosion, luminal obliteration & epithelial sequestrationsequestration

• Lymphohistiocytic, proliferative interstitial pneumoniaLymphohistiocytic, proliferative interstitial pneumonia• Peribronchiolar and septal fibroplasiaPeribronchiolar and septal fibroplasia

Lymphoid LesionsLymphoid Lesions: Lymphoid depletion and replacement : Lymphoid depletion and replacement of follicles with macrophages, intracytoplasmic inclusionsof follicles with macrophages, intracytoplasmic inclusions

LiverLiver: Hepatocellular necrosis and lymphoplasmacytic : Hepatocellular necrosis and lymphoplasmacytic inflammationinflammation

KidneyKidney: Lymphoplasmacytic interstitial nephritis: Lymphoplasmacytic interstitial nephritis

Lung LesionsLung Lesions• Bronchial and bronchiolar epithelial attenuation, Bronchial and bronchiolar epithelial attenuation,

hyperplasia, erosion, luminal obliteration & epithelial hyperplasia, erosion, luminal obliteration & epithelial sequestrationsequestration

• Lymphohistiocytic, proliferative interstitial pneumoniaLymphohistiocytic, proliferative interstitial pneumonia• Peribronchiolar and septal fibroplasiaPeribronchiolar and septal fibroplasia

Lymphoid LesionsLymphoid Lesions: Lymphoid depletion and replacement : Lymphoid depletion and replacement of follicles with macrophages, intracytoplasmic inclusionsof follicles with macrophages, intracytoplasmic inclusions

LiverLiver: Hepatocellular necrosis and lymphoplasmacytic : Hepatocellular necrosis and lymphoplasmacytic inflammationinflammation

KidneyKidney: Lymphoplasmacytic interstitial nephritis: Lymphoplasmacytic interstitial nephritis

Differential Diagnosis of Necrotizing Bronchitis and Bronchiolitis in SwineDifferential Diagnosis of Necrotizing Bronchitis and Bronchiolitis in Swine

SIV and PRCV• epithelial necrosis• epithelial attenuation• epithelial hyperplasia• mononuclear cuffing

SIV and PRCV• epithelial necrosis• epithelial attenuation• epithelial hyperplasia• mononuclear cuffing

PCV2• epithelial necrosis• epithelial attenuation• epithelial hyperplasia• mononuclear cuffing• peribronchiolar fibrosis• luminal obliteration• epithelial sequestration

PCV2• epithelial necrosis• epithelial attenuation• epithelial hyperplasia• mononuclear cuffing• peribronchiolar fibrosis• luminal obliteration• epithelial sequestration

Porcine Circovirus: DiagnosisPorcine Circovirus: Diagnosis Clinical signs and gross lesions very similar to PRRSClinical signs and gross lesions very similar to PRRS unique microscopic lesions and inclusion bodiesunique microscopic lesions and inclusion bodies immunohistochemistry (IHC), immunohistochemistry (IHC), in situin situ hybridization hybridization

(ISH) to confirm association of virus with lesion(ISH) to confirm association of virus with lesion virus isolation and serology available in some labsvirus isolation and serology available in some labs

• offered at ISU VDLoffered at ISU VDL

• ubiquitous virus so value and interpretation of ubiquitous virus so value and interpretation of serologic information is difficultserologic information is difficult

• attempt virus isolation in recurrent cases to have attempt virus isolation in recurrent cases to have virus available for potential autogenous vaccine virus available for potential autogenous vaccine productionproduction

PMWS Case ObservationsPMWS Case Observations PMWS concurrent infectionsPMWS concurrent infections

• confirm confirm PRRSVPRRSV in 60% of the cases, in 60% of the cases, – suspect PRRSV is involved in 80% of the casessuspect PRRSV is involved in 80% of the cases

• other common concurrent infectionsother common concurrent infections– SIV, HPS/SIV, HPS/S. suis, M. hyo.S. suis, M. hyo.

Mortality much higher in concurrent infection Mortality much higher in concurrent infection casescases• acute SIV + circovirus + acute SIV + circovirus + M. hyoM. hyo. pneumonia cases. pneumonia cases

– 2-10% mortality in finishers2-10% mortality in finishers• chronic PRDC due to PRRSV + M hyo + PMWSchronic PRDC due to PRRSV + M hyo + PMWS

– 10-15% mortality in finishers10-15% mortality in finishers

PMWS Case ObservationsPMWS Case Observations Duration of disease in a system variesDuration of disease in a system varies

• often a single batch problem in smaller, often a single batch problem in smaller, single-site herds that use internal gilt single-site herds that use internal gilt replacementsreplacements

• increasing number of cases where PMWS increasing number of cases where PMWS has become endemic in multiple building has become endemic in multiple building finishing sitesfinishing sites

Porcine Circovirus: PathogenesisPorcine Circovirus: Pathogenesis PMWS strains (PMWS strains (Type 2Type 2) differ from PK/15 cell ) differ from PK/15 cell

culture strains (culture strains (Type 1Type 1))• genetically types 1 and 2 are quite differentgenetically types 1 and 2 are quite different

– multiplex PCR can differentiatemultiplex PCR can differentiate• PCV1 is nonpathogenic in growing pigs (Allan et al.)PCV1 is nonpathogenic in growing pigs (Allan et al.)• evidence that “evidence that “shaker pig diseaseshaker pig disease” may be caused ” may be caused

by PCV1 or PCV2by PCV1 or PCV2 High seroprevalence of PCV2 but limited casesHigh seroprevalence of PCV2 but limited cases

• tested 27 high health herds with no clinical evidence tested 27 high health herds with no clinical evidence of PMWSof PMWS

– 100% or herds seropositive for PCV2100% or herds seropositive for PCV2– high percent of animals within a herd positivehigh percent of animals within a herd positive– passive antibody decay by 10-20 weekspassive antibody decay by 10-20 weeks

Experimental Reproduction of Experimental Reproduction of PMWSPMWS

Ellis et al., 1999Ellis et al., 1999• reproduced PMWS lesions in CDCD pigs inoculated reproduced PMWS lesions in CDCD pigs inoculated

with tissue filtrates; both PCV2 and PPV detectedwith tissue filtrates; both PCV2 and PPV detected Allan et al. 1999; and Kennedy et al. 2000Allan et al. 1999; and Kennedy et al. 2000

• inoculated colostrum-deprived pigs with PCV2 inoculated colostrum-deprived pigs with PCV2 alone, PPV alone, and PCV2+PPV; reproduced alone, PPV alone, and PCV2+PPV; reproduced severe disease and lesions typical of PMWS in severe disease and lesions typical of PMWS in dually-inoculated group whereas only mild lesions dually-inoculated group whereas only mild lesions and subclinical disease was reproduced in the and subclinical disease was reproduced in the PCV2 only groupPCV2 only group

Krakowka et al. 2000Krakowka et al. 2000• reproduced disease and PMWS lesions in reproduced disease and PMWS lesions in

gnotobiotic pigs co-infected with PCV2 and PPVgnotobiotic pigs co-infected with PCV2 and PPV

Experimental Experimental PCV2/PRRSV Co-InfectionPCV2/PRRSV Co-Infection

Experimental Experimental PCV2/PRRSV Co-InfectionPCV2/PRRSV Co-Infection

Field cases suggested interactionField cases suggested interaction Objective:Objective:

• Reproduce disease seen in field casesReproduce disease seen in field cases• Develop model to study the interactionDevelop model to study the interaction• Develop model for evaluating intervention Develop model for evaluating intervention

strategiesstrategies

Field cases suggested interactionField cases suggested interaction Objective:Objective:

• Reproduce disease seen in field casesReproduce disease seen in field cases• Develop model to study the interactionDevelop model to study the interaction• Develop model for evaluating intervention Develop model for evaluating intervention

strategiesstrategies

Experimental DesignExperimental DesignExperimental DesignExperimental Design 4 groups of 3 week old CD/CD pigs

• Control 9 pigs• PCV2 19 pigs• PRRSV 13 pigs• PRRSV/PCV2 17 pigs

Intranasal inoculation of PRRSV and PCV2

Scheduled necropsies at 7,10,14,21,35,49 days post-inoculation

4 groups of 3 week old CD/CD pigs• Control 9 pigs• PCV2 19 pigs• PRRSV 13 pigs• PRRSV/PCV2 17 pigs

Intranasal inoculation of PRRSV and PCV2

Scheduled necropsies at 7,10,14,21,35,49 days post-inoculation

Clinical Respiratory Scores

0

1

2

3

4

5

6

7 10 11-14 15-21

Days

Control

PCV

PRRSV

PCV/PRRSV

Mean Gross Lung Scores

01020304050

60708090

100

7-10 11-14 15-21

Days

% L

un

g A

ffec

ted

Control

PCV

PRRSV

PCV/PRRSV

Summary of Findings: PCV2-Summary of Findings: PCV2-PRRSV Co-infectionPRRSV Co-infection

Summary of Findings: PCV2-Summary of Findings: PCV2-PRRSV Co-infectionPRRSV Co-infection

PCV2 GroupPCV2 Group• Minimal respiratory diseaseMinimal respiratory disease• Mortality of 40% between 10-30 DPI Mortality of 40% between 10-30 DPI • Mild necrotizing bronchiolitis, minimal Mild necrotizing bronchiolitis, minimal

pneumoniapneumonia• Lymphoid depletion, necrotizing hepatitisLymphoid depletion, necrotizing hepatitis

PRRSV groupPRRSV group• Moderate respiratory diseaseModerate respiratory disease• Mortality = 0%Mortality = 0%• Interstitial pneumonia, no airway lesionsInterstitial pneumonia, no airway lesions

PCV2 GroupPCV2 Group• Minimal respiratory diseaseMinimal respiratory disease• Mortality of 40% between 10-30 DPI Mortality of 40% between 10-30 DPI • Mild necrotizing bronchiolitis, minimal Mild necrotizing bronchiolitis, minimal

pneumoniapneumonia• Lymphoid depletion, necrotizing hepatitisLymphoid depletion, necrotizing hepatitis

PRRSV groupPRRSV group• Moderate respiratory diseaseModerate respiratory disease• Mortality = 0%Mortality = 0%• Interstitial pneumonia, no airway lesionsInterstitial pneumonia, no airway lesions

Summary of Findings: Summary of Findings: PCV2-PRRSV Co-infectionPCV2-PRRSV Co-infection

Summary of Findings: Summary of Findings: PCV2-PRRSV Co-infectionPCV2-PRRSV Co-infection

PCV2/PRRSV groupPCV2/PRRSV group

• Severe respiratory diseaseSevere respiratory disease

• Mortality >90% between 10-21 DPIMortality >90% between 10-21 DPI

• Necrotizing and ulcerative Necrotizing and ulcerative bronchiolitisbronchiolitis

• Severe interstitial pneumoniaSevere interstitial pneumonia

• Lymphoid depletion, necrotizing Lymphoid depletion, necrotizing hepatitishepatitis

PCV2/PRRSV groupPCV2/PRRSV group

• Severe respiratory diseaseSevere respiratory disease

• Mortality >90% between 10-21 DPIMortality >90% between 10-21 DPI

• Necrotizing and ulcerative Necrotizing and ulcerative bronchiolitisbronchiolitis

• Severe interstitial pneumoniaSevere interstitial pneumonia

• Lymphoid depletion, necrotizing Lymphoid depletion, necrotizing hepatitishepatitis

Experimental Evidence for PRRSV-Experimental Evidence for PRRSV-Induced Potentiation of PMWSInduced Potentiation of PMWS

Harms et al, 2000Harms et al, 2000• Reproduction of severe disease and lesions Reproduction of severe disease and lesions

typical of PMWS in CDCD pigs co-infected with typical of PMWS in CDCD pigs co-infected with PCV2 and PRRSVPCV2 and PRRSV

• Less severe disease, mortality, and lesions in Less severe disease, mortality, and lesions in PCV2 only groupPCV2 only group

• No evidence of PPV infectionNo evidence of PPV infection Allan et al., 2000Allan et al., 2000

• Experimental infection of CD piglets with PCV2 Experimental infection of CD piglets with PCV2 and PRRSV potentiates PCV2 replicationand PRRSV potentiates PCV2 replication

Activation of the Immune System May Lead to Activation of the Immune System May Lead to Increased Susceptibility to PCV2-induced PMWS?Increased Susceptibility to PCV2-induced PMWS?

Allan et al., 2000 Vet Rec; Krakowka et al., Vet Path, IN Allan et al., 2000 Vet Rec; Krakowka et al., Vet Path, IN PRESS. Activation of macrophages in lymphoid tissues PRESS. Activation of macrophages in lymphoid tissues of colostrum fed pigs may lead to potentiation of PCV2 of colostrum fed pigs may lead to potentiation of PCV2 replication and development of clinical disease and replication and development of clinical disease and lesions typical of PMWSlesions typical of PMWS

– 7/7 colostrum fed pigs inoculated with PCV2 and then 7/7 colostrum fed pigs inoculated with PCV2 and then immunized with keyhole limpet haemocyanin (in Freund’s immunized with keyhole limpet haemocyanin (in Freund’s incomplete adjuvant) developed clinical disease and lesions incomplete adjuvant) developed clinical disease and lesions typical of PMWS whereas subclinical disease and minimal typical of PMWS whereas subclinical disease and minimal lesions were reproduced in PCV2-inoculated pigs without lesions were reproduced in PCV2-inoculated pigs without immunizationimmunization

– 3/14 pigs vaccinated with M. hyo (2 dose) and APP (1 dose) 3/14 pigs vaccinated with M. hyo (2 dose) and APP (1 dose) developed PMWS whereas 0/14 unvaccinated pigs developed PMWS whereas 0/14 unvaccinated pigs developed PMWS developed PMWS

Control of PMWSControl of PMWS Confirm PMWS/circovirus by necropsy, histopath, IHC, Confirm PMWS/circovirus by necropsy, histopath, IHC,

ISHISH Identify farm, site, or system specific concurrent Identify farm, site, or system specific concurrent

infectionsinfections• eliminate PRRSV from the mix if possibleeliminate PRRSV from the mix if possible

– work to avoid simultaneous coinfectionwork to avoid simultaneous coinfection– focus on breeding herd stabilization and pig flowfocus on breeding herd stabilization and pig flow

• eliminate/control SIV with vaccinationeliminate/control SIV with vaccination• further explore role of PPV and use of PPV vaccinefurther explore role of PPV and use of PPV vaccine• minimize effects of minimize effects of M. hyoM. hyo. with vaccination and . with vaccination and

medicationmedication• treat bacterial coinfectionstreat bacterial coinfections• anti-inflammatories (aspirin, ketoprofen) usefulanti-inflammatories (aspirin, ketoprofen) useful

PMWS Summary and ConclusionsPMWS Summary and Conclusions

PMWS has become a major disease in PMWS has become a major disease in the U.S.the U.S.

Field and experimental evidence Field and experimental evidence supports a major role for PCV2 in supports a major role for PCV2 in PMWSPMWS

Field evidence also supports a role for Field evidence also supports a role for PCV2 in porcine respiratory disease PCV2 in porcine respiratory disease complexcomplex